Literature DB >> 20056755

Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.

David R McIlroy1, Gebhard Wagener, H Thomas Lee.   

Abstract

BACKGROUND AND OBJECTIVES: Neutrophil gelatinase-associated lipocalin (NGAL) is rapidly released by renal tubules after injury, potentially allowing early identification of acute kidney injury (AKI) after cardiac surgery. However, the diagnostic performance of NGAL has varied widely in clinical studies, and it remains unknown what factors modify the relationship between NGAL and AKI. We hypothesized the relationship between urinary NGAL and AKI would vary with baseline renal function, allowing a stratified analysis to improve diagnostic performance of this novel biomarker. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a prospective observational study in 426 adult cardiac surgical patients. Urinary NGAL was serially determined, commencing preoperatively and continuing 24 hours postoperatively. AKI was defined as increase in serum creatinine from baseline by either >50% or >0.3 mg/dl within 48 hours postoperatively. Patients were stratified by baseline estimated GFR (eGFR). NGAL levels were compared between patients with and without AKI and diagnostic characteristics determined according to baseline eGFR.
RESULTS: In patients with baseline eGFR >or=60 ml/min, urinary NGAL was higher at all postoperative time points in patients who developed AKI compared with those who did not. In patients with baseline eGFR <60 ml/min, urinary NGAL did not differ at any time between those who did and those who did not develop AKI. Postoperative NGAL best identified AKI in patients with baseline eGFR 90 to 120 ml/min.
CONCLUSIONS: The relationship between urinary NGAL and AKI after cardiac surgery varies with baseline renal function, with optimal discriminatory performance in patients with normal preoperative function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056755      PMCID: PMC2827603          DOI: 10.2215/CJN.04240609

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  32 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.

Authors:  Marc Froissart; Jerome Rossert; Christian Jacquot; Michel Paillard; Pascal Houillier
Journal:  J Am Soc Nephrol       Date:  2005-01-19       Impact factor: 10.121

4.  Fallacy of indexing renal and systemic hemodynamic measurements for body surface area.

Authors:  S T Turner; S L Reilly
Journal:  Am J Physiol       Date:  1995-04

5.  Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.

Authors:  S Ohlsson; J Wieslander; M Segelmark
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

6.  Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery.

Authors:  Mark Stafford-Smith; Mihai Podgoreanu; Madhav Swaminathan; Barbara Phillips-Bute; Joseph P Mathew; Elizabeth H Hauser; Michelle P Winn; Carmelo Milano; Dahlia M Nielsen; Mike Smith; Richard Morris; Mark F Newman; Debra A Schwinn
Journal:  Am J Kidney Dis       Date:  2005-03       Impact factor: 8.860

7.  Supra-normal creatinine clearance in black mild hypertensive patients in Nigeria.

Authors:  T A Odutola; S B Ositelu; E A D'Almeida; J C Okeiyi
Journal:  J Hum Hypertens       Date:  1988-08       Impact factor: 3.012

Review 8.  Renal functional reserve in subjects with diabetes mellitus.

Authors:  S L Jones; G Viberti
Journal:  Semin Nephrol       Date:  1995-09       Impact factor: 5.299

9.  Accuracy of body mass index categories based on self-reported height and weight among women in the United States.

Authors:  Benjamin M Craig; Alexandra K Adams
Journal:  Matern Child Health J       Date:  2008-07-08

10.  Renal reserve filtration capacity in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  P M ter Wee; E van Ballegooie; J B Rosman; S Meijer; A J Donker
Journal:  Nephrol Dial Transplant       Date:  1987       Impact factor: 5.992

View more
  66 in total

1.  Urinary Angiotensinogen Level Predicts AKI in Acute Decompensated Heart Failure: A Prospective, Two-Stage Study.

Authors:  Xiaobing Yang; Chunbo Chen; Jianwei Tian; Yan Zha; Yuqin Xiong; Zhaolin Sun; Pingyan Chen; Jun Li; Tiecheng Yang; Changsheng Ma; Huafeng Liu; Xiaobin Wang; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2015-02-26       Impact factor: 10.121

2.  NGAL and AKI: the end of a myth?

Authors:  Matthieu Legrand; Michael Darmon; Michael Joannidis
Journal:  Intensive Care Med       Date:  2013-08-16       Impact factor: 17.440

Review 3.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

Review 4.  Cardiac surgery-associated acute kidney injury.

Authors:  Huijuan Mao; Nevin Katz; Wassawon Ariyanon; Lourdes Blanca-Martos; Zelal Adýbelli; Anna Giuliani; Tommaso Hinna Danesi; Jeong Chul Kim; Akash Nayak; Mauro Neri; Grazia Maria Virzi; Alessandra Brocca; Elisa Scalzotto; Loris Salvador; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

5.  New markers of acute kidney injury: giant leaps and baby steps.

Authors:  Zoltán H Endre; John W Pickering
Journal:  Clin Biochem Rev       Date:  2011-05

6.  Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.

Authors:  Isidro Torregrosa; Carmina Montoliu; Amparo Urios; María Jesús Andrés-Costa; Carla Giménez-Garzó; Isabel Juan; María Jesús Puchades; María Luisa Blasco; Arturo Carratalá; Rafael Sanjuán; Alfonso Miguel
Journal:  Heart Vessels       Date:  2014-07-03       Impact factor: 2.037

Review 7.  Marking renal injury: can we move beyond serum creatinine?

Authors:  Jessica L Slocum; Michael Heung; Subramaniam Pennathur
Journal:  Transl Res       Date:  2012-02-03       Impact factor: 7.012

8.  Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR.

Authors:  Jay L Koyner; Steven G Coca; Heather Thiessen-Philbrook; Uptal D Patel; Michael G Shlipak; Amit X Garg; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2015-09-16       Impact factor: 8.860

Review 9.  Acute kidney injury after cardiovascular surgery: an overview.

Authors:  Juan Jose Olivero; Juan Jorge Olivero; Peter Tuan Nguyen; Anna Kagan
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Jul-Sep

10.  α-Intercalated cells defend the urinary system from bacterial infection.

Authors:  Neal Paragas; Ritwij Kulkarni; Max Werth; Kai M Schmidt-Ott; Catherine Forster; Rong Deng; Qingyin Zhang; Eugenia Singer; Alexander D Klose; Tian Huai Shen; Kevin P Francis; Sunetra Ray; Soundarapandian Vijayakumar; Samuel Seward; Mary E Bovino; Katherine Xu; Yared Takabe; Fábio E Amaral; Sumit Mohan; Rebecca Wax; Kaitlyn Corbin; Simone Sanna-Cherchi; Kiyoshi Mori; Lynne Johnson; Thomas Nickolas; Vivette D'Agati; Chyuan-Sheng Lin; Andong Qiu; Qais Al-Awqati; Adam J Ratner; Jonathan Barasch
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.